Archives of Serum Pharmacology?

The Archives of Serum Pharmacology is a manuscript and documentary collection held at the Wellcome Library in London since 1983, containing institutional records, clinical trial data, and correspondence from the major serum therapy research and manufacturing centers of the 1970s and 1980s. The collection is the largest surviving documentation of serum therapy development during the decade that serum therapy emerged as the first clinically viable systemic alternative to the azo drugs.

The archive comprises approximately 4,000 individual items: patient case files, statistical tables, laboratory protocols, interinstitutional correspondence between the Infectious Disease Research Centre in Cambridge, the Pasteur Institute in Paris, and the specialized serum farms that supplied clinical material. The bulk of the collection originates from the Cambridge centre, which transferred its records in 1981 after the successful completion of the Halloway-Umezaki trials. Additional donations came from retired researchers associated with Dorothy Umezaki's team and from administrators at three hyperimmunized animal facilities in Scotland, England, and Denmark.

The archive is organized chronologically and by institution. The earliest materials date from 1968, when the Cambridge centre was founded, and the collection extends through 1982. Major holdings include:

The Infectious Disease Research Centre core collection (1968-1981) comprises laboratory notebooks, serum batch records with antibody titer measurements, statistical analyses of patient survival, and donor animal genealogies maintained for the herds used in antibody production. The records document the centre's progression from preliminary serum therapy trials on bacterial endocarditis to the large-scale clinical validation that preceded the method's formal licensure.

Interinstitutional correspondence between Margaret Saunders (Cambridge), Dorothy Umezaki (later at the same centre), and European collaborators at the Pasteur Institute and the Institute for the History of Bacteriology in Berlin spans 1972-1980. These exchanges document the gradual refinement of antibody selection criteria, the coordination of patient populations for trial purposes, and disputes over statistical methodology—particularly debates about how to measure clinical efficacy when recovery was often incomplete and reinfection remained possible.

Serum farm records from three production facilities detail the maintenance of hyperimmunized animal colonies, breeding protocols, immunization schedules, and batch purification procedures. These materials reveal the logistical constraints that limited serum therapy availability before 1979: each production facility maintained only 200-400 animals capable of yielding therapeutic-grade serum, and the time required to immunize and produce usable antibodies meant a lag of 6-8 weeks from patient need to serum availability.

Patient case files comprise approximately 800 individual records from Cambridge trials, each containing clinical presentation, serum therapy dose and source, follow-up observations over 12-24 months, and outcome notation (recovery, partial recovery, death). The collection preserves the uncertainty characteristic of serum therapy: many patients showed marked clinical improvement without complete bacterial clearance, and reinfection was documented in 18-22% of surviving patients. These files form the basis of the statistical analysis that established serum therapy's efficacy sufficiently to justify clinical adoption, despite outcomes that would have been considered inadequate in any competing antibacterial system.

Statistical working papers and calculation sheets document the mathematical justification for licensure. The most extensively annotated materials relate to survival analysis by the Kaplan-Meier method, a technique adapted for serum therapy trials because conventional cure rates were inappropriate when bacterial elimination was incomplete. The papers show prolonged debate about what constituted clinical success and how to reconcile partial recovery, recurring infection, and mortality into a coherent measure.

Access to the collection is by appointment and subject to researcher registration with the Wellcome Library. Certain case files remain closed under British medical confidentiality rules, though redacted statistical summaries are available. The archive catalogue was completed in 1987 and updated in 1998; digital finding aids became available in 2003.

The Archives of Serum Pharmacology has been cited in approximately twelve monographs and forty peer-reviewed articles examining serum therapy development, the history of asepsis maximalism, and statistical methods in twentieth-century medicine. The collection is particularly valuable for documenting the practical constraints on serum production and the clinical uncertainties that persisted even after the method's adoption, providing evidence for the argument among medical historians that late-twentieth-century infection medicine remained organized around prevention and containment rather than definitive cure, despite the availability of serum therapy.

In 2008, Margaret Saunders, one of the archive's primary donors, published a memoir drawing extensively on the collection's correspondence and case notes, offering a first-hand account of serum therapy's development and the institutional pressures surrounding its licensure. Her account emphasized the role of unpublished clinical setbacks and the gradual accumulation of evidence rather than any single breakthrough discovery.